| |
 |
Tripentones: A Promising Series of Potent Anti-Cancer Agents
|
| |
|
pp.369-380 (12) Authors: Christophe Rochais, Patrick Dallemagne, Sylvain Rault |
| |
|
|
| |
|
Novel Implications for Lysophospholipids, Lysophosphatidic Acid and Sphingosine 1-Phosphate, as Drug Targets in Cancer
|
| |
|
pp.381-391 (11) Author: Olivier Peyruchaud |
| |
|
|
| |
|
The Effects of Cantharidin and Cantharidin Derivates on Tumour Cells
|
| |
|
pp.392-396 (5) Authors: Dongwu Liu, Zhiwei Chen |
| |
|
|
| |
|
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
|
| |
|
pp.397-414 (18) Authors: K. L. Vine, L. Matesic, J. M. Locke, M. Ranson, D. Skropeta |
| |
|
|
| |
|
Recent Advances in the Development of P-gp Inhibitors
|
| |
|
pp.415-436 (22) Authors: Christiane Baumert, Andreas Hilgeroth |
| |
|
|
| |
|
Discovery of 4-Aryl-4H-Chromenes as Potent Apoptosis Inducers Using a Cell- and Caspase-Based Anti-Cancer Screening Apoptosis Program (ASAP): SAR Studies and the Identification of Novel Vascular Disrupting Agents
|
| |
|
pp.437-456 (20) Authors: Sui Xiong Cai, John Drewe, William Kemnitzer |
| |
|
|
| |
|
Anticancer Actions of Omega-3 Fatty Acids – Current State and Future Perspectives
|
| |
|
pp.457-470 (14) Authors: Martina Wendel, Axel R. Heller |
| |
|
|
| |
|
Urea Derivatives as Anticancer Agents
|
| |
|
pp.471-480 (10) Authors: Huan-Qiu Li, Peng-Cheng Lv, Tao Yan, Hai-Liang Zhu |
| |
|
|
